Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236079 · ClinicalTrials.gov registry record · NA
Cessation Service Use and Effectiveness for Hospitalized Smokers
A NA study of Smoking, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 3
- Study locations
NCT01236079: Completed NA study of Smoking, sponsored by Kaiser Permanente.
NCT01236079 is a NA study of Smoking that has completed, run by Kaiser Permanente. The registered enrollment target is 900 participants, above the 448-participant average among 123 other Smoking trials with a reported enrollment target (101% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01236079, a NA study of Smoking, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this patient-randomized effectiveness trial is to demonstrate that an inpatient technology-supported assisted referral (I-TSAR) and follow-up approach is an effective and cost-effective method to help hospitalized patients successfully quit smoking. The proposed study represents a unique opportunity to assess the effectiveness and cost-effectiveness of linking inpatient and outpatient delivery of smoking cessation services in two large and very different health care delivery systems. We will enroll 900 participants (600 intervention, 300 controls) over 15-months and collect follow-up survey and health care utilization data over 12 months to estimate: 1) smoking abstinence at 6 and 12 months for I-TSAR intervention recipients compared to usual care; 2) the dose effect on smoking abstinence at 6 and 12 months for I-TSAR recipients compared to usual care; 3) total and mean costs per participant for I-TSAR and usual care recipients, and, if effective, estimate the incremental cost-effectiveness of the intervention vs. controls at 12 months from health plan/insurer and societal perspectives; and 4) differences in health care utilization at 12 months for I-TSAR versus controls.
Conditions Studied
Interventions
- BEHAVIORAL Assisted referral & IVR
Study Locations (3)
Oregon
- Kaiser Permanente Sunnyside - Clackamas
- Legacy Emanuel Hospital - Portland
- Oregon Health & Science Univeristy - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT01236079 record still lists
NCT01236079 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 448-participant average among 123 other Smoking trials with a reported enrollment target (101% higher).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Assisted referral & IVR is the first listed.
NCT01236079 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01236079 about?
NCT01236079 is a clinical study titled "Cessation Service Use and Effectiveness for Hospitalized Smokers". The goal of this patient-randomized effectiveness trial is to demonstrate that an inpatient technology-supported assisted referral (I-TSAR) and follow-up approach is an effective and cost-effective method to help hospitalized patients successfully quit smoking. The proposed study represents a unique...
What is the current status of trial NCT01236079?
This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2011-12. Estimated completion is 2016-07.
What conditions does trial NCT01236079 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT01236079?
The interventions under investigation include: Assisted referral & IVR (BEHAVIORAL).
Who is sponsoring clinical trial NCT01236079?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01236079 being conducted?
This trial has 3 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01236079's enrollment target sits among peer trials
900 15th of 123 higher than 109 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia